• 18 MAR 16

    Avicenna Pain prize for Karin Faber

    Neurologist prof. dr. Karin Faber from the Maastricht UMC+ received the Avicenna Pain prize 2016 for the research into small fibre neuropathy. The prize was awarded to her by dr. Dolf Boerman, neurologist.

    Read more →
    • 22 FEB 16

    MRI study in patients with small fibre neuropathy

    In 2016 a study will start on brain scanning (functional MRI or fMRI) in patients with small fibre neuropathy. Patients with a (probable) pathogenic mutation in the sodium channel SCN9A gene or with an abnormal skin biopsy without gene mutation are eligible for this study. The aim is to study brain activity in these patient

    Read more →
    • 22 FEB 16

    Research into genetic causes in painful neuropathy.

    Neuropathic pain is a frequent feature of peripheral neuropathy, adversely impacting patients’ quality of life. Not all individuals with peripheral neuropathy develop pain and it is not possible to predict who will develop pain. Moreover, current treatments are often disappointing. The PROPANE (Probing the role of sodium channels in painful neuropathies) Study aims to find

    Read more →
    • 22 FEB 16

    Cornea confocal microscopy in patients with possible small fibre neuropathy

    From the beginning of 2016 all patients referred for possible small fibre neuropathy are offered the possibility to have an ophthalmologic examination being performed. With this so-called cornea confocal microscopy we determine the small nerve fibre density in the cornea of both eyes. This pain free technique may contribute to the diagnosis of small fibre

    Read more →
    • 22 FEB 16

    Treatment for small fibre neuropathy

    In July 2016 a new study will start using intravenous immunoglobulins for the treatment of pain in patients with small fibre neuropathy. Immunoglobulins are proteins, present in human blood, that are involved in the immune system. These immunoglobulins have been described to influence pain in some very small studies. Patients that are eligible for this

    Read more →
    • 04 JAN 16

    Saving together for future studies

    Finding an effective treatment for myotonic dystrophy as soon as possible. To cure patients or at least be able to treat the consequences of the disease. This is the shared dream of patients, investigators and the Prinses Beatrix Spierfonds. For more information, click here.

    Read more →